chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lethargy; aches/some lingering aches; fevers; severe stabbing pains in the center of her chest/stabbing chest pain; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number: unknown), via an unspecified route of administration, administered in Arm Right on Jan2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient Concomitant medications included levothyroxine sodium (SYNTHROID). The patient reported was received the first dose of the Pfizer COVID Vaccine last January and had a pretty significant response to it. She mentioned that she had all the expected side effects such as lethargy, aches/ some lingering aches, and fevers but by the second day she had severe stabbing pains in the center of her chest/ stabbing chest pain. Because of this she opted not to get the second dose. She mentioned that because of the changing times and states requiring full vaccination, she is considering of getting vaccinated. She is asking when she can receive her second dose and for what to do if her side effects arise again after the second dose. She states she made it through it by taking Tylenol. She is a little concerned about taking the second one. She says that with everything going on it looks like she made need to do that. She wants to know are here things she can do to ward off the side effects. She doesn't have an anaphylactic reaction but since its been such a long time should she get the vaccine if she wants to do. she says that with everything going on it looks like she made need to do that all from an unspecified date. The clinical outcome of the events was recovered on unspecified date.  No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to allow appropriate reporting to health authorities.
Patient began complaining of aches and pains. They were unexplained and no injury found. By the September the pain became too much and her body began to shut down.
High Fever, chills, fatigue, headache, dizziness, body aches and loss of appatite.  Felt like I had COVID19 all over again (tested positive on 11/18/2020).
Vomiting, Dizziness, Headache, Muscle Ache, Stomach Ache Took 2 Tums antacid and went to bed. Woke up feeling dizzy, headache, muscle aches, lethargic, face swelling.
Woke up in severe body pain night of vaccine. My entire body was shaking and I could not stand from 1am-3am. Took ibuprofen and pain subsided.  24 hours after injection, site became red and under arm began to swell. Lymph nodes continued to swell so much that I could not straighten my arm. The peak of enlargement was Sunday Feb 6, over 48 hours after shot. Armpit continued to be enlarged until Wednesday February 10. Arm site was red and started to stripe red around to armpit. Redness faded around Wednesday February 10.
I had dry mouth, difficulty breathing, and long-term cough. I tested negative for COVID-19 several times. I went to the doctor and they gave me an inhaler which did not do anything. I got to the point to where I couldn't hear properly in my right ear. It was sinus blockage and I had to get surgery on my nose cavity so I could breathe better. This helped but I just got an infection in my nose, and I am still coughing and stuffy.
Strange skin reaction; Looked like red thread from the injection site and down to his elbow/ like a straight line; This spontaneous case was received on 02-Oct-2020 from a pharmacist via Health Authority (reference number: SEQW20-02779) and concerned a 56-year-old, male patient.   The patient's medical history and concomitant medications were not reported.   On 01-Oct-2020, the patient was vaccinated with Afluria Quadrivalent [influenza vaccine; dose: 0.5 ml; route of administration: intramuscular; anatomical location: deltoid] for influenza prophylaxis. The batch number reported was P100240258 and expiry date was 26-May-2021.  On 02-Oct-2020, one day after vaccination, in the morning, the patient observed a strange skin reaction. It looked like a red thread from the injection site and down to his elbow and it looked like a straight line. No corrective treatment was applied for events.  At the time of initial reporting on 02-Oct-2020, the patient had not recovered from events.   The reporter assessed events as non-serious.  The reporter did not provide a causality assessment.  Company comment: A 56-year old, male patient was administered Afluria Quadrivalent vaccine. The patient developed skin reaction and erythema (reported as red thread from the injection site and down to his elbow and it looked like a straight line) one day after receiving vaccine. The patient's medical history and concomitant medications were not reported. With information available, causality is assessed as possibly related due to plausible chronology and location of the event.; Sender's Comments: A 56-year old, male patient was administered Afluria Quadrivalent vaccine. The patient developed skin reaction and erythema (reported as red thread from the injection site and down to his elbow and it looked like a straight line) one day after receiving vaccine. The patient's medical history and concomitant medications were not reported. With information available, causality is assessed as possibly related due to plausible chronology and location of the event.
First dose received Pfizer (batch/lot# EN5318). No AE noted as per client. No treatment received.
10OCT92 raised rash chest, arms & face; c/o joint pain, lo grade temp, flu like sxs, alot of neck pain & h/a every day since vax; 19OCT still not feeling better;
OPTICAL MIGRAINE (EACH TIME THE MIGRAINES LASTED ABOUT 10 TO 15 MINUTES); This spontaneous report received from a patient concerned a 69 year old female. The patient's height, and weight were not reported. The patient's past medical history included: migraine headaches, and concurrent conditions included: social drinker, and non-smoker, and other pre-existing medical conditions included: The patient had no known drug allergies and the patient was not a drug abuse or illicit drug user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-AUG-2021, the patient experienced optical migraine (each time the migraines lasted about 10 to 15 minutes). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from optical migraine (each time the migraines lasted about 10 to 15 minutes). This report was non-serious.
tenderness at the injection site that has continued to worsen since 6/23 injection. Employee health was notified 7/5 of the R arm pain. no redness, warmth or swelling. small knot palpated b y the urgent care physician. She would not allow me to palpate the arm due tto pain.
Severe joint pain, muscle aches, chills, nausea and low grade fever 99.8
BREATHING PROBLEMS; THICK HEAVY/SWOLLEN LEGS; LOW BLOOD PRESSURE; PRESSURE IN BREAST AREA; LUMP AT INJECTION SITE; HOT URINE; HUGE RASH ON ARM, SHOULDER AND BACK; INJECTION SITE PAIN/ PAIN DURING INJECTION; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced pressure in breast area. On 30-MAR-2021, the subject experienced lump at injection site. On 30-MAR-2021, the subject experienced hot urine. On 30-MAR-2021, the subject experienced huge rash on arm, shoulder and back. On 30-MAR-2021, the subject experienced injection site pain/ pain during injection. On 10-APR-2021, the subject experienced breathing problems. On 10-APR-2021, the subject experienced thick heavy/swollen legs. On 10-APR-2021, the subject experienced low blood pressure. Laboratory data included: Blood pressure (NR: not provided) LOW, and Oxygen saturation (NR: not provided) 90s down to 83. On 13-APR-2021, Laboratory data included: Electrocardiogram (NR: not provided) No issue in Heart, and X-ray (NR: not provided) No issue in lungs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from breathing problems, thick heavy/swollen legs, and injection site pain/ pain during injection on 18-APR-2021, low blood pressure on 10-APR-2021, pressure in breast area on 30-MAR-2021, lump at injection site on 17-APR-2021, hot urine on 01-APR-2021, and huge rash on arm, shoulder and back on 19-APR-2021. This report was non-serious.
Mother referred to HD approx. 3:30 with child c/o swollen eyes with itching, flushing, cough, difficulty breathing. Vaccines adm approx 2:55. Mom states lives 5 minutes away 3:40 EMT arrived. B/P 90/50 P-112 transported to hospital.
My Wife was on her period when having the flu shot. She had hard periods before but it was cured . it affected her in a Bad way and started Bleeding in a way that she fainted . Had to call EMS . I don't know the type of the flu shot.
p/vax pt had problem breathing;also c/o being dizzy;T99 & stomach complaints, arm still sore;lump @ site of inj;pt went to school nurse;mom was not called from school;
This spontaneous report received from a patient concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for an unspecified indication. No concomitant medications were reported. On an unspecified date, the patient experienced condition aggravated, and drug effect decreased/Humira stopped working. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient recovered from drug effect decreased/Humira stopped working, and the outcome of condition aggravated was not reported. This report was non-serious.
Approximately two days after my vaccine, I started having heart palpitations about 3-4 times a day.  I have never had heart palpitations previously.  I continue to have the palpitations.  I previously had a positive Covid-19 test on November 26, 2020.  I had very minor symptoms.  I went to the emergency room on 03/25/2021 to be assessed.
Pt started feeling light-headed and nauseous 10 min after vaccine was administered. Pt  then threw up a little and then started complaining  of altered breathing and chest pain. 911 was called, paramedics arrived and assessed, vitals were normal. Pt then with consent of legal guardian decided they wanted to be transported to hospital to get checked out.
Heart stopped suddenly after 18 days probably due to presence of Potassium Chloride in the injection. Outcome DEATH within 2 hours thereof as medics unable to regain consciousness after CPR.
Leg pain; Cold legs; Chills; Muscle pain; Headache; Feverish; Knee joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Leg pain), PERIPHERAL COLDNESS (Cold legs), CHILLS (Chills), MYALGIA (Muscle pain) and HEADACHE (Headache) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (Leg pain), PERIPHERAL COLDNESS (Cold legs), CHILLS (Chills), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Feverish) and ARTHRALGIA (Knee joint pain). The patient was treated with ACETAMINOPHEN (oral) at a dose of 200 milligram, 2 Tablets. At the time of the report, PAIN IN EXTREMITY (Leg pain), PERIPHERAL COLDNESS (Cold legs), CHILLS (Chills), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Feverish) and ARTHRALGIA (Knee joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
I got second shot on a Tuesday AM.I started to get achy, severe headache and a fever 12 hours after shot at 1030 pm. Next morning symptoms continued for the day and night. I also notice what I thought was a mosquito bite on my arm 24 hrs after injection. By 48 hours fever was gone and symptoms lessened thru out the day. I had another bump on torso which I thought was a mosquito bite. By Friday I was feeling much better. On Saturday I woke up with terrible hives and itching. For 2 days, Saturday and Sunday, I had severe hives and itching all over my body. I took Benadryl every 5 hours. On Monday (today) the hives were less and not as irritated.
Janssen COVID-19 vaccine EUA  Woke up around 4:00 am - 4:30 am with a mild head ache with minor pressure around where the nose bridge intersects the eyebrows. Along with some minor nausea.
Patient received Monovalent for his booster and according to guidelines starting 09/01/2022 patient should have received Bivalent. Patient notified he qualifies for Bivalent after 11/01/2022, appointment scheduled on 11/03/2022 for Bivalent.
Fever, chills, body aches, headache, mild nausea momentarily x 2, sleeplessness , severe injection site pain and mild swelling ( no redness ).
left arm tingling starting from above left elbow radiating to left face-started at 10:38 on 12/30/20 and resolved at 18:30-19:30 pm on 12/30/2020
Angioedema, Rash REDNESS, ITCHING HEAT Narrative: ITCHING, REDNESS, AND HEAT AT INJECTION SITE FOR 24HOURS
WHOLE BODY HURTS; VOMITING; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a 28 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 09:15 in left arm for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, approximately at 16:00 the subject experienced whole body hurts. On 24-MAR-2021, approximately at 16:00 the subject experienced vomiting. On 24-MAR-2021, approximately at 16:00 the subject experienced fever. On 24-MAR-2021, approximately at 16:00 the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from whole body hurts, fever, headache, and vomiting. This report was non-serious.
Painful raised red lesions located arms and legs, painful to touch and itching. Patients also states he feels flushed/warms. He has but anti-itch cream on the lesions which helps.
Dizziness, UrticariaPruritus, HYPERtension, facial flushing, face felt warm
had a sore arm; This is a spontaneous report from a non-contactable consumer. A male patient (reporter's husband) of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 24Mar2021 at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient had a sore arm after his Pfizer vaccine on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Narrative: 66yo male with hx of COPD, dementia, diastolic dysfunction, PVD, HTN, heavy smoker, depression, DM, obesity, & seizure disorder died on 7/14/2021. Likely death is not related to the vaccination given date of death is >90 days post vaccination.
pt recvd vax;devel large abscess,initially presenting as redness & pain, at the inject site over a two wk period p/ adm of vax;tx by incision & drainage & ATB as an outpt;reporter noted adverse event due to inadequate needlenght in obese pt
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer Pfizer concerned a 33 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy unspecified, and other pre-existing medical conditions included: None. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 042A21A expiry: Unknown) dose was not reported, 1 total administered to left arm on 02-APR-2021 for prophylactic vaccination. Age at time of vaccination 4 decade old.  The patient received additional non-company suspect vaccine included: Moderna Covid-19 Vaccine (elasomeran) (form of admin, route of admin were not reported, batch number: 088D21A expiry: Unknown) dose was not reported, administered to left arm on 13-AUG-2021 for prophylactic vaccination. Age at time of vaccination 4 decade old.  The patient received non-company suspect Paxlovid (Nirmatrelvir; ritonavir) (form of admin, route of admin, batch number and expiry were not reported) therapy started on 23-MAY-2022, Therapy ended on 27-MAY-2022 administered for covid-19 treatment. No concomitant medications were reported. On an unspecified date in MAY-2022, the patient had covid-19 infection (dose number in series 2) (suspected covid-19 infection) which led to suspected clinical vaccination failure (dose number in series 1). On 23-MAY-2022 patient started treatment with Paxlovid. On 31-MAY-2022 at 21:00 (4 days after stopping treatment), the patient had rebound of covid-19. It started with intense congestion and then the rest of the symptoms followed (dose number in series 2).  The action taken with covid-19 vaccine ad26.cov2.s, and elasomeran was not applicable and with paxlovid was not reported. The patient was recovering from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000235216.; Sender's Comments: V0:20220618811-Covid-19 vaccine ad26.cov2.s-Suspected clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
So on approximately 5/6/2021 I started having some pain, discomfort and vertigo - tightness in my chest and what not. Then I could not see out of my right eye when I went to sleep as well. Then I was having some balancing issues too, I went to the ER on the 6th of May and then the 10th of May as well. I called my DR because I was having headaches and the other issues as well, he told me to go to the ER. The ER did some tests and ruled out neurological issues. My PCD told me it was probably a complex migraine, a reaction from the vaccine. He gave me medication for five days -methylprednisolone 4MG. I went to the eye DR as well and they documented my right eye lack of vision. The eye DR told me to hold off about a month before getting any glasses or anything like that. After four weeks, my vision was doing better and the balance and other things they were better but not my normal. I went to the eye DR again after that time frame and they said my vision had returned. I do not know when everything as a whole went back to normal, but I do feel fine now.
The day after receiving my vaccines I was hot and cold with some body aches. I went to the restroom and passed out. I hit my head and twisted my ankle. I went to the ER department and they stated my ankle was sprung and I had a concussion. They did not give me any treatment but did advised me the reaction was from the vaccine. My ankle was sore for a few weeks, my head was sore for only 24 hours, and hot and cold sweats went on for about 24 hours.
Night sweats began immediately and have not stopped.  I attributed it to menopause; however, I have been having hot flashes for three years and this is different.  It didn't dawn on me that it could be from vaccine until recently.  I have been researching and saw where others have had same thing.  Then my husband has recently been having night sweats.  He received the Moderna around the same time.  I also have a close circle of friends who work food pantry with me.  Four out of six have had same symptoms when we started discussing.  Three of them are men.
PATIENT STATED SHE RECEIVED THE PPSV23 IN HER DELTOID AND BOOSTRIX IN HER TRICEP AREA.  SHE HAD EXCRUTIATING PAIN UPON ADMINISTRATION AND AFTER. SHE BELIEVES THE SHOT WAS GIVEN TOO HIGH IN THE DELTOID. SHE SEEKED MEDICAL CARE WITH HER PROVIDER 4 DAYS LATER AND HE STARTED HER ON PHYSICAL THERAPY FOR HER SHOULDER PAIN AND LOSS OF RANGE OF MOTION IN HER LEFT ARM. PATIENT HAD MRI IN JANUARY DUE TO CONTINUED PAIN AND LOSS OF RANGE OF MOTION. DIAGNOSED WITH TENDON TEARS AND FROZEN SHOULDER. PATIENT HAD SHOULDER SURGERY ON 15 MARCH TO RELEASE FROZEN SHOULDER.
With the second dose, I broke out into a full body rash that required a steroid shot to alleviate.  It occurred 1 month after the second dose of the moderns vaccine was administered.  I wasn?t sure if it was related, so I didn?t report.  I just received the booster less than 2 weeks ago and I?m breaking out into a full body rash again.  Red, raised welts that are very itchy and burn at certain sites.  The rash always begins at my elbows and spreads over my entire body.  The reaction from the booster occurred more rapidly and now showing signs on my face which hadn?t happened with the prior shot.  The reactions appear to be getting more severe.  Within 18 hours of first signs, I have welts over my ankles, face, stomach, elbows, hands, etc
Initial report received from a pharmacist on 22 Dec 2009: This patient, with an unknown medical history, was vaccinated with previously frozen FLUVIRIN (batch no. 102135P1), intramuscularly, on 21 Dec 2009. No adverse event was reported. No other information was provided.
DTap was given in right leg on 1/18/06.  Patients leg started swelling late that evening.  Next day pt's whole thigh was swollen from him to knee.  There was some erythema measuring 10x7inches-Patient had leg pain the first day but none since.  No fevers.
Headache, Myalgia, Fever, NauseaVomiting, Worst body aches she has ever experienced. Narrative:
swelling below the injection site; fatigue; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling below the injection site), FATIGUE (fatigue) and MYALGIA (muscle aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE SWELLING (swelling below the injection site), FATIGUE (fatigue) and MYALGIA (muscle aches). At the time of the report, VACCINATION SITE SWELLING (swelling below the injection site), FATIGUE (fatigue) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.